Genta Expects Genasense Appeal Decision This Quarter After FDA Extends Review
Company previously had expected to hear from FDA in Q4 2007 following formal appeal of “not approvable” letter for CLL.
Company previously had expected to hear from FDA in Q4 2007 following formal appeal of “not approvable” letter for CLL.